Here, while analyzing the separase proteolytic activity in circulating MNCs/CD34+ cells in patients with CML under TKI treatment, we observed the occurrence of a small number of cells with conspicuously enhanced levels of separase activity. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.